Palvella Therapeutics (PVLA) Shareholder's Equity Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.46% |
| Dec 31, 2025 | -2.04% |
| Sep 30, 2025 | -2.41% |
| Jun 30, 2025 | 0.47% |
| Mar 31, 2025 | 2.22% |
| Dec 31, 2024 | 4.04% |
| Sep 30, 2024 | -44.20% |
| Jun 30, 2024 | -43.80% |
| Mar 31, 2024 | -35.39% |
| Dec 31, 2023 | -31.05% |
| Sep 30, 2023 | -9.50% |
| Jun 30, 2023 | -6.05% |
| Mar 31, 2023 | -21.14% |
| Dec 31, 2022 | -58.93% |
| Jun 30, 2022 | 36.58% |
| Mar 31, 2022 | 24.27% |
| Dec 31, 2021 | 15.01% |
| Sep 30, 2021 | 11.33% |
| Jun 30, 2021 | 4.61% |
| Mar 31, 2021 | 7.07% |
| Dec 31, 2020 | -0.06% |
| Sep 30, 2020 | 5.36% |
| Jun 30, 2020 | 33.16% |
| Mar 31, 2020 | 28.48% |
| Dec 31, 2019 | 23.32% |
| Sep 30, 2019 | 644.26% |
| Jun 30, 2019 | 354.80% |
| Mar 31, 2019 | 475.53% |
| Dec 31, 2018 | 132.72% |
| Jun 30, 2018 | 551.13% |